Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVAC in Organ-Confined Bladder Cancer Based on p53 Status
NCT00005047Phase 3Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Aug 1997
- Primary completion
- Mar 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of methotrexate, vinblastine, doxorubicin, cisplatin in bladder cancer, sponsored by SWOG Cancer Research Network. Started Aug 1997; status: terminated.
02
Drugs
methotrexatevinblastinedoxorubicincisplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00005047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005047.